Registered Number:12403147 |
For the year ended 31 January 2024
England and Wales
Unaudited Financial Statements
For the year ended 31 January 2024
Route1 Pharma Limited
Contents Page
1
Statement of Financial Position
2 to 4
Notes to the Financial Statements
Route1 Pharma Limited
Statement of Financial Position
2023
2024
Property, plant and equipment |
874,365
582,050
2
874,365
582,050
95,000
127,000
3
Trade and other receivables |
13,991
43,316
4
155,607
Cash and cash equivalents |
111,789
282,105
264,598
Trade and other payables: amounts falling due within one |
year |
(250,855)
(260,572)
5
13,743
21,533
Net current assets
Total assets less current liabilities |
895,898
595,793
Trade and other payables: amounts falling due after more |
than one year |
(485,558)
(614,800)
6
281,098
Net assets
110,235
2
2
281,096
110,233
281,098
110,235
Shareholders' funds
For the year ended 31 January 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006 |
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each |
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and |
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as |
applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
Miss Puneeta Joshi Director |
These financial statements were approved and authorised for issue by the Board on 12 March 2024 and were signed by: |
The notes form part of these financial statements |
1 of 4
For the year ended 31 January 2024
Route1 Pharma Limited
Notes to the Financial Statements
Statutory Information
Route1 Pharma Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number |
12403147. |
46A Dukes Wood Avenue
Buckinghamshire
Gerrards Cross
England
SL9 7JU
The presentation currency is £ sterling. |
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting Standard |
102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The |
financial statements have been prepared under the historical costs convention as modified by the revaluation of certain assets. |
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes. |
Property, plant and equipment
Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Plant and Machinery
Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss. |
Inventories
Inventories are value at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme for the benefit of its directors/and employees. Contributions payable are charged to the profit and loss account in the period in which they are payable. |
2 of 4
For the year ended 31 January 2024
Route1 Pharma Limited
Notes to the Financial Statements Continued
2. Property, plant and equipment |
600,000
80,000
520,000
301,908
1,908
300,000
820,000
81,908
901,908
Provision for depreciation and impairment |
17,950
17,950
-
Charge for year
9,593
9,593
-
27,543
27,543
-
820,000
54,365
874,365
520,000
62,050
582,050
2023
2024
127,000
95,000
4. Trade and other receivables |
2023
2024
43,316
13,991
5. Trade and other payables: amounts falling due within one year |
2023
2024
Taxation and social security |
67,644
22,773
192,928
228,082
260,572
250,855
3 of 4
For the year ended 31 January 2024
Route1 Pharma Limited
Notes to the Financial Statements Continued
6. Trade and other payables: amounts falling due after more than one year |
2023
2024
614,800
485,558
7. Average number of persons employed |
During the year the average number of employees was 0 (2023 : 6)
4 of 4